Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?


OverviewForecastRevenueFinancialsChart

Werewolf Therapeutics Ownership Summary


Werewolf Therapeutics is owned by 2.98% institutional investors, 6.07% insiders, and 90.95% retail investors. Ra capital management is the largest institutional shareholder, holding 13.71% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.00% of its assets in Werewolf Therapeutics shares.

HOWL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockWerewolf Therapeutics2.98%6.07%90.95%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.14M13.71%$5.97M
Mpm asset management4.28M9.80%$6.34M
Pfm health sciences, lp2.51M5.59%$2.44M
Bioimpact capital2.41M5.37%$2.34M
Bank of america corp /de/2.15M5.16%$5.24M
Blackrock funding, inc. /de1.70M3.89%$2.52M
Blackrock1.59M3.82%$3.87M
Vanguard group1.42M3.25%$2.10M
Rubric capital management lp1.33M2.98%$1.30M
Millennium management784.62K1.75%$762.80K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dc funds, lp589.10K24.47%$871.87K
Mpm asset management4.28M5.10%$6.34M
Bioimpact capital2.41M0.40%$2.34M
Pfm health sciences, lp2.51M0.18%$2.44M
Sphera funds management626.81K0.17%$927.68K
Ra capital management6.14M0.10%$5.97M
Rubric capital management lp1.33M0.02%$1.30M
Bridgeway capital management109.59K0.00%$162.19K
Financial perspectives6.75K0.00%$9.99K
Regal investment advisors27.20K0.00%$40.26K

Top Buyers

HolderShares% AssetsChange
Blackrock1.59M0.00%1.42M
Bank of america corp /de/2.15M0.00%266.31K
Millennium management784.62K0.00%188.33K
Deutsche bank ag\101.63K0.00%83.17K
Blackrock funding, inc. /de1.70M0.00%63.38K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---2.00M
Monashee investment management---890.00K
Eagle health investments lp---700.00K
Pfm health sciences, lp2.51M0.18%-398.94K
Verition fund management---233.83K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp33.86K-33.86K$50.12K
D. e. shaw17.78K-17.78K$26.31K
Intech investment management14.87K0.00%14.87K$22.00K
Larson financial group10.00K0.00%10.00K$14.80K
Bnp paribas arbitrage, snc6.83K-6.83K$10.11K

Sold Out

HolderChange
Nisa investment advisors-40.00
Capital performance advisors llp-60.00
Russell investments group-86.00
Point72 (difc)-381.00
Macquarie group-940.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-98.65%1,333,893-95.26%20.07%--100.00%--100.00%
Dec 31, 202445-35.71%5,479,410-82.99%120.23%28-28.21%8-33.33%
Sep 30, 202469-4.17%31,964,492-0.84%731.22%38-15.56%12-7.69%
Jun 30, 20247214.29%32,236,039-0.05%771.00%4515.38%138.33%
Mar 31, 20246346.51%32,252,02716.56%881.46%3969.57%1271.43%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv895.75K2.00%-
Vanguard US Total Market Shares ETF800.28K1.79%-
iShares Russell 2000 ETF665.66K1.48%327.00
HBM Healthcare Investments AG Ord396.80K0.91%-60.51K
Vanguard Institutional Extnd Mkt Idx Tr392.16K0.87%-
Fidelity Small Cap Index312.00K0.70%-
BIT Biotech Opportunities S241.06K0.54%-
iShares Russell 2000 Value ETF200.35K0.45%-
Fidelity Extended Market Index170.17K0.38%4.93K
Vanguard Russell 2000 ETF151.59K0.34%8.55K

Recent Insider Transactions


DateNameRoleActivityValue
May 12, 2025RA CAPITAL MANAGEMENT, L.P. Buy$275.99K
May 13, 2025RA CAPITAL MANAGEMENT, L.P. Buy$51.91K
May 14, 2025RA CAPITAL MANAGEMENT, L.P. Buy$159.29K
Mar 27, 2025MPM BioVentures 2014, L.P.-Sell$2.06K
Mar 27, 2025EVNIN LUKE Sell$2.55K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q1--
2024 Q2--
2024 Q1--
2023 Q2--

HOWL Ownership FAQ


Who Owns Werewolf Therapeutics?

Werewolf Therapeutics shareholders are primarily institutional investors at 2.98%, followed by 6.07% insiders and 90.95% retail investors. The average institutional ownership in Werewolf Therapeutics's industry, Biotech Stocks , is 63.96%, which Werewolf Therapeutics falls below.

Who owns the most shares of Werewolf Therapeutics?

Werewolf Therapeutics’s largest shareholders are Ra capital management (6.14M shares, 13.71%), Mpm asset management (4.28M shares, 9.80%), and Pfm health sciences, lp (2.51M shares, 5.59%). Together, they hold 29.10% of Werewolf Therapeutics’s total shares outstanding.

Does Blackrock own Werewolf Therapeutics?

Yes, BlackRock owns 3.82% of Werewolf Therapeutics, totaling 1.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.87M$. In the last quarter, BlackRock increased its holdings by 1.42M shares, a 863.47% change.

Who is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested, with 24.47% of its assets in 589.1K Werewolf Therapeutics shares, valued at 871.87K$.

Who is the top mutual fund holder of Werewolf Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Werewolf Therapeutics shares, with 2.00% of its total shares outstanding invested in 895.75K Werewolf Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools